Clinical Trials Directory

Trials / Completed

CompletedNCT05834270

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
Male
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia

Conditions

Interventions

TypeNameDescription
DRUGSingle dose tamsulosin 0.4mgSingle dose tamsulosin 0.4mg
DRUGDouble dose tamsulosin 0.4mgDouble dose tamsulosin 0.4mg

Timeline

Start date
2022-05-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2023-04-28
Last updated
2023-04-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05834270. Inclusion in this directory is not an endorsement.

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH (NCT05834270) · Clinical Trials Directory